A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
Journal of Clinical Investigation · 01.03.2021 · 131 (5)
DOI: 10.1172/jci140794 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.03.2021. Verfasst von Kenta Matsuda und 27 weiteren Autor:innen. Beteiligte Einrichtung: HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Ma…. Hauptthemen laut MEDLINE: Genetic Vectors. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Centers of Influenza Virus Research and Surveillance.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Biostatistics Research Branch, NIAID and.
- Trans-NIH Center for Human Immunology, Autoimmunity, and Inflammation, NIH, Bethesda, Maryland, USA.
- Emergent Biosolutions Inc., Gaithersburg, Maryland, USA.
Förderung
- NIAID NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Centers of Influenza Virus Research and Surveillance
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Matsuda, K., Migueles, S. A., Huang, J., Bolkhovitinov, L., Stuccio, S., Griesman, T., Pullano, A. A., Kang, B. H., Ishida, E., Zimmerman, M., Kashyap, N., Martins, K. M., Stadlbauer, D., Pederson, J., Patamawenu, A., Wright, N., Shofner, T., Evans, S., Liang, C. J., …, & Connors, M. (2021). A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. Journal of Clinical Investigation, 131(5). https://doi.org/10.1172/jci140794
Vancouver
Matsuda K, Migueles SA, Huang J, Bolkhovitinov L, Stuccio S, Griesman T, et al. A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. Journal of Clinical Investigation. 2021;131(5). doi:10.1172/jci140794
BibTeX
@article{Matsuda2021,
author = {Matsuda, Kenta and Migueles, Stephen A and Huang, Jinghe and Bolkhovitinov, Lyuba and Stuccio, Sarah and Griesman, Trevor and Pullano, Alyssa A and Kang, Byong H and Ishida, Elise and Zimmerman, Matthew and Kashyap, Neena and Martins, Kelly M and Stadlbauer, Daniel and Pederson, Jessica and Patamawenu, Andy and Wright, Nathaniel and Shofner, Tulley and Evans, Sean and Liang, C Jason and Candia, Julián and Biancotto, Angelique and Fantoni, Giovanna and Poole, April and Smith, Jon and Alexander, Jeff and Gurwith, Marc and Krammer, Florian and Connors, Mark},
title = {A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity},
journal = {Journal of Clinical Investigation},
year = {2021},
volume = {131},
number = {5},
doi = {10.1172/jci140794}
}
EUVIMED